0001415889-16-004608.txt : 20160204 0001415889-16-004608.hdr.sgml : 20160204 20160204083110 ACCESSION NUMBER: 0001415889-16-004608 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160204 DATE AS OF CHANGE: 20160204 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Medovex Corp. CENTRAL INDEX KEY: 0001591165 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88823 FILM NUMBER: 161386884 BUSINESS ADDRESS: STREET 1: 3729 HARDEE AVENUE CITY: ATLANTA STATE: GA ZIP: 30341 BUSINESS PHONE: (404) 393-6989 MAIL ADDRESS: STREET 1: 3729 HARDEE AVENUE CITY: ATLANTA STATE: GA ZIP: 30341 FORMER COMPANY: FORMER CONFORMED NAME: SpineZ DATE OF NAME CHANGE: 20131105 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Honig Renee Hersey CENTRAL INDEX KEY: 0001640877 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: 555 S. FEDERAL HIGHWAY #450 CITY: BOCA RATON STATE: FL ZIP: 33432 SC 13G/A 1 rhonig13ga_feb32016.htm SCHEDULE 13G/A rhonig13ga_feb32016.htm


 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

Amendment No. 3
To
SCHEDULE 13G
(Rule 13d-102)


INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(b)


MEDOVEX CORP.
(Name of Issuer)
 
 
COMMON STOCK
(Title of Class of Securities)

58504H101
(CUSIP Number)


February 4, 2016
(Date of Event Which Requires Filing of This Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[   ] Rule 13d-1(b)
[ x] Rule 13d-1(c)
[   ] Rule 13d-1(d)


 
 



 

 
CUSIP No. 58504H101
 

 
1
 
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
Renee Honig
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                                       (a) x
                                                                                                                                                             (b) ¨
 
3
 
SEC USE ONLY
 
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
 
 
NUMBER OF SHARES
 
5
 
SOLE VOTING POWER
 
325,000
 
BENEFICIALLY
OWNED BY
 
6
 
SHARED VOTING POWER
 
705,346(1)
 
EACH
REPORTING
 
7
 
SOLE DISPOSITIVE POWER
 
325,000
 
PERSON WITH
 
8
 
SHARED DISPOSITIVE POWER
 
 705,346 (1)
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 1,030,346(1)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
9.33% (based on 11,048,203 shares of common stock outstanding as of February 3, 2016)
 
12
 
TYPE OF REPORTING PERSON*
 
IN

(1)  
Includes (i) 310,133 shares of common stock held by spouse, Barry Honig, (ii) 379,427 shares of common stock held by GRQ Consultants, Inc. Roth 401K FBO Barry Honig (the “Roth 401K”) and (iii) 15,786 shares of common stock held by Marlin Capital Investments, LLC (“Marlin”). Barry Honig is the trustee of the Roth 401K and the Managing Member of Marlin, and in such capacities, has voting and dispositive power over the securities held by such entities. Excludes 90,762 shares of common stock underlying Series A Warrants held by Barry Honig as to which the holder may not convert or exercise, as applicable, in excess of 4.99% together with all shares owned.


 
 

 
 
Item 1(a).                Name of Issuer:

Medovex Corp., a Nevada corporation (“Issuer”)

Item 1(b).                Address of Issuer's Principal Executive Offices:

3279 Hardee Avenue
Atlanta, Georgia 30341

Item 2(a).                Name of Person Filing.

The statement is filed on behalf of Renee Honig (the “Reporting Person”).

Item 2(b).                Address of Principal Business Office or, if None, Residence.

555 South Federal Highway #450, Boca Raton, FL 33432

Item 2(c).                Citizenship.

Renee Honig is a citizen of the United States.

Item 2(d).                Title of Class of Securities.

Common Stock, par value $0.001.

Item 2(e).                CUSIP Number.

58504H101

Item 3.                     Type of Person

Not applicable.

Item 4.                     Ownership.

(a) Amount beneficially owned:  1,030,346(1)

(b) Percent of class:  9.33% (based on 11,048,203 shares of common stock outstanding as of February 3, 2016)

(c) Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote: 325,000
(ii) Shared power to vote or to direct the vote:  705,346(1)
(iii) Sole power to dispose or to direct the disposition of: 325,000
(iv) Shared power to dispose or to direct the disposition of:  705,346(1)
 
________________________
(1)  
Includes (i) 310,133 shares of common stock held by spouse, Barry Honig, (ii) 379,427 shares of common stock held by GRQ Consultants, Inc. Roth 401K FBO Barry Honig (the “Roth 401K”) and (iii) 15,786 shares of common stock held by Marlin Capital Investments, LLC (“Marlin”). Barry Honig is the trustee of the Roth 401K and the Managing Member of Marlin, and in such capacities, has voting and dispositive power over the securities held by such entities. Excludes 90,762 shares of common stock underlying Series A Warrants held by Barry Honig as to which the holder may not convert or exercise, as applicable, in excess of 4.99% together with all shares owned.
 
 
 
 

 
 
Item 5.                     Ownership of Five Percent or Less of a Class.

Not applicable.

Item 6.                     Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7.                     Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company.
 
Not applicable.

Item 8.                     Identification and Classification of Members of the Group.

Not applicable.

Item 9.                     Notice of Dissolution of Group.

Not applicable.

Item 10.                   Certifications.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 
 

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 4, 2016
By: 
/s/ Renee Honig
 
   
Renee Honig